This coalition of PDPs has nearly 300 potential new technologies in their collective pipelines. More than 100 of those products are in late-stage development. These efforts are driven significantly by partnerships across various sectors and geographies and represent a critical opportunity to make considerable progress against or eradicate some of the world’s deadliest and most persistent threats to global health, including those that disproportionately impact women and children.
PDP pipelines are robust and poised to deliver a significant number of innovative technologies in the near term
Previous
Previous
PDPs are the global leaders in developing new health technologies where lack of traditional market incentives have stalled progress
Next
Next